NOTE 10 - STOCKHOLDERS' DEFICIT |
3 Months Ended |
|---|---|
Mar. 31, 2026 | |
| Notes | |
| NOTE 10 - STOCKHOLDERS' DEFICIT | NOTE 10 – STOCKHOLDERS’ DEFICIT
The Company is authorized to issue 295,000,000 shares of common stock, $0.0001 par value per share, and 5,000,000 shares of undesignated preferred stock, $0.0001 par value per share. The Board of Directors has the authority to establish one or more series of preferred stock and to determine the designations, preferences, rights, and restrictions of each series. No shares of preferred stock were issued or outstanding as of March 31, 2026 or December 31, 2025.
Common Stock Activity
Common stock transactions during the three months ended March 31, 2026 were as follows:
·On January 16, 2026, the Company issued 50,000 restricted shares of common stock for legal services rendered in connection with the Company’s S-1 registration statement. The stock was valued at $3,500 based on the closing market price of the Company’s common stock on the date of issuance. ·In March 2026, the Company granted Restricted Stock Awards (“RSA’s”) totaling 130,000 shares of common stock. See Note 11. As a result of these transactions, the Company had 19,105,950 shares of common stock outstanding as of March 31, 2026.
There were no common stock transactions during the three months ended March 31, 2025 |